BRIEF published on 02/05/2025 at 07:35, 1 year 9 months ago JCDecaux Strengthens Its Digital Presence in London Innovation Digital Advertising Infrastructure London JCDecaux
BRIEF published on 02/05/2025 at 07:10, 1 year 9 months ago Gradual Return of ElecLink Operations Announced Energy Security ElecLink Electricity Interconnector Revenue Impact France-UK
BRIEF published on 02/05/2025 at 07:10, 1 year 9 months ago Annonce de la reprise progressive des activités d'ElecLink Sécurité Énergétique Lien Électronique Impact Sur Les Revenus France-Royaume-Uni Interconnexion Électrique
BRIEF published on 02/05/2025 at 07:05, 1 year 9 months ago Valneva Achieves UK Approval for World's First Chikungunya Vaccine Public Health Valneva Chikungunya Vaccine UK Approval Travel Safety
BRIEF published on 02/05/2025 at 07:05, 1 year 9 months ago Valneva obtient l'approbation du Royaume-Uni pour le premier vaccin contre le chikungunya au monde Valneva Santé Publique Vaccin Contre Le Chikungunya Approbation Du Royaume-Uni Sécurité En Voyage
BRIEF published on 02/05/2025 at 06:50, 1 year 9 months ago Gurit Receives EcoVadis Gold Medal for Sustainability Excellence Sustainability Corporate Responsibility Environmental Commitment EcoVadis Gold Medal Gurit
BRIEF published on 02/05/2025 at 06:50, 1 year 9 months ago Gurit reçoit la médaille d'or EcoVadis pour l'excellence en matière de développement durable Engagement Environnemental Durabilité Responsabilité D'entreprise Médaille D'or EcoVadis Gurit
BRIEF published on 02/05/2025 at 06:35, 1 year 9 months ago Lotus Pharmaceutical Partners with Formycon to Commercialize Eylea® Biosimilar in Asia-Pacific Lotus Pharmaceutical Eylea® Biosimilar Asia-Pacific Commercialization FDA And EU Approval Retinal Disease Treatment
BRIEF published on 02/05/2025 at 06:35, 1 year 9 months ago Lotus Pharmaceutical s'associe à Formycon pour commercialiser le biosimilaire Eylea® en Asie-Pacifique Lotus Pharmaceutique Biosimilaire Eylea® Commercialisation En Asie-Pacifique Approbation De La FDA Et De L'UE Traitement Des Maladies De La Rétine
BRIEF published on 02/05/2025 at 02:10, 1 year 9 months ago Volcon, Inc. Launches Proposed Public Offering Electric Vehicles Public Offering Volcon Aegis Capital Nasdaq VLCN
Published on 11/05/2026 at 13:30, 15 minutes ago Gemdale Gold Reports Strong Metallurgical Test Results at its Pontio Gold Project: Gold Recoveries of +91% and Copper Recoveries up to 87.5%
Published on 11/05/2026 at 13:29, 16 minutes ago Impauer Technologies Announces Official Release of PauerOne V2 Featuring Integrated PauerEarn Rewards Engine
Published on 11/05/2026 at 13:27, 18 minutes ago AI/ML Innovations Inc. Announces Proposed Private Placement
Published on 11/05/2026 at 13:00, 45 minutes ago NOA Lithium Provides Update On 2026 Exploration Campaign
Published on 11/05/2026 at 13:35, 9 minutes ago DeFi Technologies' Subsidiary Valour Launches Eight New Digital Asset ETPs on Spotlight Stock Market, Expanding Access to AI, Institutional Blockchain, DeFi and Community Tokens
Published on 11/05/2026 at 13:15, 29 minutes ago Global Higher Education Forum Highlights Hong Kong’s Strategic Vision as International Talent Hub
Published on 11/05/2026 at 13:05, 39 minutes ago TR-1: Standard Form for Notification of Major Holdings
Published on 11/05/2026 at 13:05, 39 minutes ago Anaheim Bio Launches with €40 Million Series A Financing to Advance ANA-1 for Calcium Pyrophosphate Deposition Disease into the Clinic
Published on 11/05/2026 at 13:05, 39 minutes ago movement Acquires Technology and IP Assets of Swiss Digital Health Company dacadoo
Published on 11/05/2026 at 10:16, 3 hours 28 minutes ago Accélération confirmée au troisième trimestre 2026 Tous les métiers en croissance, chiffre d’affaires en progression de +6,5 %
Published on 11/05/2026 at 10:16, 3 hours 28 minutes ago Growth acceleration confirmed in the third quarter of 2026 All businesses growing, revenue up +6,5%
Published on 11/05/2026 at 07:00, 6 hours 45 minutes ago Accélération confirmée au troisième trimestre 2026 Tous les métiers en croissance, chiffre d’affaires en progression de +6,5 %
